Journal
/
Immunology and Infection
/
Killer Artificial células presentadoras de antígenos (KaAPC) para la utilización eficiente<em> In Vitro</em> El agotamiento de células T humanas específicas de antígeno
JoVE Journal
Immunology and Infection
This content is Free Access.
JoVE Journal Immunology and Infection
Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
Please note that all translations are automatically generated. Click here for the English version.

Killer Artificial células presentadoras de antígenos (KaAPC) para la utilización eficiente<em> In Vitro</em> El agotamiento de células T humanas específicas de antígeno

español

Automatically Generated

9,483 Views

•

08:12 min

•

August 11, 2014

DOI:

10.3791/51859-v

DOI:
10.3791/51859-v

•

08:12 min
August 11, 2014

•

3 Views
, , ,
1Department of Pathology, Institute of Cell Engineering,Johns Hopkins University, 2Department of Internal Medicine I,University of Regensburg, 3Department of Rheumatology,Asklepios Medical Center

Explore More Videos

Killer Artificial Antigen Presenting CellsKaAPCIn Vitro T Cell DepletionAutoimmune Disease TreatmentCell-based ImmunotherapyAntigen-specific T Cell ModulationGlobal ImmunosuppressionTolerance-inducing Antigen Presenting Cells

Read Article

Cite this Article

Schütz, C., Fleck, M., Schneck, J. P., Oelke, M. Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells. J. Vis. Exp. (90), e51859, doi:10.3791/51859 (2014).

Download .ris file

Copy

Share Video

.

Copy